CMS de­tails pro­gram to use out­comes-based agree­ments to pay for sick­le cell gene ther­a­pies

US Med­ic­aid pro­grams will test a pay­ment mod­el that will re­im­burse mul­ti­mil­lion-dol­lar gene ther­a­pies based on pa­tient out­comes, in an ear­ly step to­ward ef­forts to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.